Cargando…
Coronavirus disease 2019 (COVID-19) vaccination in systemic lupus erythematosus and anti-neutrophil cytoplasmic antibody-associated vasculitis
Autores principales: | Sim, Jackie, Lim, Cynthia Ciwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084413/ https://www.ncbi.nlm.nih.gov/pubmed/33928459 http://dx.doi.org/10.1007/s10067-021-05750-3 |
Ejemplares similares
-
COVID-19 vaccination in anti-neutrophil cytoplasmic antibody-associated vasculitis: lessons from influenza vaccination?
por: Sim, Jackie, et al.
Publicado: (2022) -
Anti-neutrophil cytoplasmic antibodies in new-onset systemic lupus
erythematosus
por: Su, Fang, et al.
Publicado: (2017) -
Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis
por: Hellmark, Thomas, et al.
Publicado: (2019) -
Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Sun, Xiao-Jing, et al.
Publicado: (2023) -
Antibody response to COVID-19 booster vaccine in rituximab-treated patients with anti–neutrophil cytoplasmic antibody–associated vasculitis
por: Kant, Sam, et al.
Publicado: (2022)